Safety and Immunogenicity of SCB-2019 in Children < 18 Years of Age
Condition: COVID-19 Intervention: Biological: Candidate vaccine, SCB-2019 Sponsor: Clover Biopharmaceuticals AUS Pty Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials